Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Maha T. Barakat"'
Autor:
Aseel A. Jawabri, Anne John, Mohammad A. Ghattas, Radwa E. Mahgoub, Mohammad I. K. Hamad, Maha T. Barakat, Bindu Shobi, Hinda Daggag, Bassam R. Ali
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
BackgroundFamilial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by increased LDL-cholesterol levels. About 85% of FH cases are caused by LDLR mutations encoding the low-density lipoprotein receptor (LDLR). LDLR is synthes
Externí odkaz:
https://doaj.org/article/853e9696b4b94268b68dc340efeeb0de
Autor:
Hinda Daggag, Anette P. Gjesing, Alshafi Mohammad, Lars Ängquist, Bindu Shobi, Suma Antony, Dalia Haj, Alia Al Tikriti, Adam Buckley, Torben Hansen, Maha T. Barakat
Publikováno v:
Metabolism Open, Vol 16, Iss , Pp 100213- (2022)
Aims: To investigate the prevalence of pathogenic variants in monogenic diabetes genes in Emirati women with gestational diabetes (GDM) and examine the risk of developing hyperglycemia during follow-up in carriers and non-carriers. Methods: Female pa
Externí odkaz:
https://doaj.org/article/98499753b6fe48e9b32e131612171c55
Autor:
Katherine S Elliott, Marc Haber, Hinda Daggag, George B Busby, Rizwan Sarwar, Derek Kennet, Michael Petraglia, Lawrence J Petherbridge, Parisa Yavari, Frauke U Heard-Bey, Bindu Shobi, Tariq Ghulam, Dalia Haj, Alia Al Tikriti, Alshafi Mohammad, Suma Antony, Maitha Alyileili, Shatha Alaydaroos, Evelyn Lau, Mark Butler, Arash Yavari, Julian C Knight, Houman Ashrafian, Maha T Barakat
Publikováno v:
Molecular Biology and Evolution
Molecular Biology and Evolution, 2022, Vol.39(3) [Peer Reviewed Journal]
Molecular Biology and Evolution, 2022, Vol.39(3) [Peer Reviewed Journal]
The indigenous population of the United Arab Emirates (UAE) has a unique demographic and cultural history. Its tradition of endogamy and consanguinity is expected to produce genetic homogeneity and partitioning of gene pools while population movement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd3cc3513d0e6d26a7b6ff605dc1489e
https://hdl.handle.net/21.11116/0000-000A-322C-D21.11116/0000-000A-322E-B
https://hdl.handle.net/21.11116/0000-000A-322C-D21.11116/0000-000A-322E-B
Autor:
Ernesto Maddaloni, Nader Lessan, Alia Al Tikriti, Raffaella Buzzetti, Paolo Pozzilli, Maha T Barakat
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0131837 (2015)
To describe and to characterize clinical features of latent autoimmune diabetes in adults (LADA) compared to type 1 and type 2 diabetes in the UAE.In this cross-sectional study a dataset including 18,101 subjects with adult-onset (>30 years) diabetes
Externí odkaz:
https://doaj.org/article/fd18bfce44304441ac852dc40f76464c
Autor:
Adam Buckley, Tricia Tan, Mohamed Suliman, Carel W. le Roux, Nader Lessan, Alia Al Tikriti, Maha T Barakat
Publikováno v:
Diabetes, Obesity and Metabolism. 21:1498-1501
In this study we prospectively collected data on the use of liraglutide 3 mg in obese Arab patients. As part of routine care, 2092 patients were dispensed liraglutide 3 mg. Median age was 38 years and 77% were women. Median baseline weight was 95 kg
Autor:
Maria Majeed, Maha T Barakat, Zendra Pei-lun Lee, Richard L. Atkinson, Budour Alkaf, Nader Lessan, Koramannil R Saradalekshmi
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Prior infection with adenovirus 36 (Adv36) has been associated with increased adiposity, improved insulin sensitivity, and a lower prevalence of diabetes. This study investigated the prevalence of Adv36 seropositivity and its association with obesity
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
2308-PUB: Liraglutide 3 mg for Weight Loss in a Real-World Setting: Clinical Outcomes after 56 Weeks
Autor:
Nader Lessan, Mohamed Suliman, Adam Buckley, Tricia Tan, Maha T Barakat, Alia Al Tikriti, Carel W. le Roux
Publikováno v:
Diabetes. 68
Background: Liraglutide 3 mg was approved in the UAE for the treatment of obesity in residents with BMI >30 kg/m2 or BMI >27 kg/m2 with obesity-related complications and clinical use started in January 2017 at the Imperial College London Diabetes Cen